Homegrown FMCG firm Jyothy Laboratories Ltd today reported a 19.95 per cent increase in consolidated net profit at Rs 26.45 crore...
Homegrown FMCG firm Jyothy Laboratories Ltd today reported a 19.95 per cent increase in consolidated net profit at Rs 26.45 crore for the third quarter ended December 31, 2014.
- Consumer staple firms may extend cost-cutting measures in FY22 to avoid adverse impact on operating margins
- FMCG sector to drive growth as India revives post lockdown 2.0; HUL, Nestle, others look fundamentally strong
- Buy these two stocks for near term gains as Nifty closing in on fresh all-time highs
The company had posted a consolidated net profit of Rs 22.05 crore during the same period of the previous fiscal, Jyothy Laboratories Ltd (JLL) said in a BSE filing.
Net sales of the company stood at Rs 356.36 crore during the quarter, up 13.72 per cent compared with Rs 313.34 crore in the year-ago period.
Commenting on the results, Jyothy Laboratories CMD M P Ramachandran said: “The enhanced spending on marketing and advertising across power brands have started to yield positive results. We have been witnessing a good traction across segments.”
During the period under review, the company’s soaps and detergent business, which includes brands like Ujala and Henko, posted sales of Rs 276.80 crore, up 12 per cent, against Rs 247.54 crore in the same period a year ago.
The company’s homecare business, which includes products such as mosquito coils, reported sales of Rs 65.51 crore, up 16 per cent, compared with Rs 56.37 crore during the year-ago period.
Jyothy Laboratories markets various brands, including Ujala, Maxo, Exo, Pril, Margo, Fa, Mr White and Henko.
Shares of Jyothy Laboratories were trading at Rs 271.95 per scrip on the BSE, down 5.98 per cent from the previous close.